<DOC>
	<DOCNO>NCT01798095</DOCNO>
	<brief_summary>Determine investigational product reference standard produce similar response .</brief_summary>
	<brief_title>Equivalence Study Specificity PPD</brief_title>
	<detailed_description>Primary : To determine 2 investigational product ( Aplisol formulate new Tuberculin PPD drug substance reference standard PPD-S2 ) produce qualitatively similar response ( positive negative ) subject uninfected M. tuberculosis ( Mtb ) mycobacteria . Secondary : 1 . To determine 2 investigational product equivalent specificity detect subject currently previously infect Mtb ; 2 . To assess tolerability investigational product term local systemic reactogenicity event .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>Males nonpregnant female , age 18 70 year Negligible risk manifest positive PPD test evidence : Prior history negative PPD test interferon gamma release assay ( IGRA ) within 14 month Screening No history Bacillus Calmette Guérin vaccination ; vaccination status uncertain , born US live outside US child No history Mtb Mtb therapy ( include isoniazid , rifampin , ethambutol , pyrazinamide , streptomycin ) No history infection atypical mycobacteria , include suspicious chest roentgenogram No history high risk medical condition ( eg , HIV infection immunosuppressive condition , severe chronic renal disease [ evidence creatinine clearance &lt; 30 ml/min ] , poorly control diabetes mellitus , silicosis , intravenous drug use , alcohol abuse ) No know close contact confirm Mtb case ( family social setting ) No history live travel India , China , SubSaharan Africa , Southeast Asia past 6 month No exposure ( casual ) highrisk environment Mtb exposure ( eg , prison , homeless shelter ) ; healthcare worker allow Subject childbearing potential unable use contraceptive ; plan pregnancy ; pregnant lactate History anaphylactic type reaction severe reaction PPD past , include history blister slough Presence condition may suppress TST reactivity , include : Protocol No . JHPAplisol03 Confidential 04 May 2012 Page 8 38 Acute viral infection , include measles , mumps , chicken pox , human immunodeficiency virus ( HIV1 , HIV2 ) . Mild viral syndrome allow . Acute bacterial infection include typhoid fever , brucellosis , typhus , leprosy , pertussis Acute systemic fungal infection Live virus vaccination within past 6 week , include measles , mumps , polio , varicella , FluMist® Metabolic derangement ( eg , poorly control diabetes , Cushing syndrome , chronic renal failure [ evidence creatinine clearance &lt; 30 ml/min ] )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>TB , Aplisol</keyword>
</DOC>